Compare BLTE & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | SEE |
|---|---|---|
| Founded | 2018 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.2B |
| IPO Year | 2021 | 1996 |
| Metric | BLTE | SEE |
|---|---|---|
| Price | $158.49 | $42.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $198.00 | $43.50 |
| AVG Volume (30 Days) | 117.4K | ★ 3.2M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | N/A | ★ 89.50 |
| EPS | N/A | ★ 3.43 |
| Revenue | N/A | ★ $5,359,800,000.00 |
| Revenue This Year | N/A | $1.93 |
| Revenue Next Year | $492.11 | $2.27 |
| P/E Ratio | ★ N/A | $12.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $56.68 | $27.34 |
| 52 Week High | $200.00 | $44.27 |
| Indicator | BLTE | SEE |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 65.73 |
| Support Level | $157.63 | $41.79 |
| Resistance Level | $161.28 | $42.21 |
| Average True Range (ATR) | 6.26 | 0.08 |
| MACD | -1.15 | 0.02 |
| Stochastic Oscillator | 17.27 | 100.00 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Sealed Air Corp is a provider of packaging solutions that integrate sustainable, high-performance materials, automation, equipment, and services. The company designs, manufactures, and delivers packaging solutions that preserve food, protect goods, and automate packaging processes. It delivers its packaging solutions to an array of end markets including fresh proteins, foods, fluids and liquids, medical and life science, e-commerce retail, logistics and omnichannel fulfillment operations, and industrials. It has two reportable segments, Food and Protective. The company generates majority of its revenue from the food segment.